-- Encore, Medidata, Monster Worldwide, VeriFone, Zeltiq: U.S. Equity Movers
-- B y   I n y o u n g   H w a n g
-- 2012-03-06T21:15:11Z
-- http://www.bloomberg.com/news/2012-03-05/activision-conocophillips-nutrisystem-verifone-u-s-equity-preview.html
Shares of the following companies
had unusual moves in U.S. trading. Stock symbols are in
parentheses and prices are as of 4 p.m. in New York.  Encore Bancshares Inc. (EBTX)   surged 35 percent, the
most since going public in 2007, to $20.19. The Houston-based
bank surged as Cadence Bancorp agreed to acquire the company for
$20.62 per share or about $250 million.  Harvest Natural Resources Inc. (HNR)   rallied 23 percent,
the most since June 2007, to $7.70. The Houston-based oil and
natural-gas company said it’s in talks to sell its 32 percent
stake in Petrodelta SA.  Medidata Solutions Inc. (MDSO)   advanced 15 percent, the
most since June 2009, to $23.97. The provider of clinical data
management software forecast first-quarter sales of $48.5
million at least, beating the average analyst estimate of $47.9
million in a Bloomberg survey.  Monster Worldwide Inc. (MWW)   rose 11 percent to $8.32
for the biggest gain in the Russell 1000 Index. The online
recruiting service hired Stone Key Partners LLC and Bank of
America Corp.’s Merrill Lynch to help it review strategic
alternatives.  Nutrisystem Inc. (NTRI)   tumbled 11 percent to $10.58,
the lowest price since May 2005. The provider of prepared meals
to help clients lose weight forecast annual earnings per share
of no more than 55 cents, falling short of the average analyst
projection of 92 cents a share, data compiled by Bloomberg show.  OmniVision Technologies Inc. (OVTI)   rose 8.4 percent,
the most since Feb. 16, to $17.16. The primary supplier of
camera sensors for  Apple Inc.’s (AAPL)   iPhone 4S was upgraded
to outperform from neutral at Robert W. Baird & Co., which cited
research showing the company may be a supplier of sensors for
Apple’s iPad3.  Oncothyreon Inc. (ONTY)   plunged 40 percent to $5.07 for
the biggest retreat in the Russell 2000 Index. The developer of
cancer treatments fell after partner  Merck KGaA (MRK)  (MRK GY) said
experimental lung-cancer drug Stimuvax remains a high-risk
project.  Quanex Building Products (NX)   dropped 7 percent, the
most since Nov. 9, to $15.48. The producer of building materials
reported a first quarter adjusted loss of 12 cents a share,
wider than the average analyst estimated loss of 3 cents a
share.  Shuffle Master Inc. (SHFL)   rose 10 percent to $16.05,
the highest price since October 2007. The maker of casino
roulette-chip sorters and card shufflers reported first-quarter
revenue of $56.1 million, beating the average analyst estimate
of $50.5 million.  Skullcandy Inc. (SKUL)  (SKUL US) slumped 8.3 percent to $13.60 and
dropped 11 percent earlier, the most intraday since Aug. 18. The
maker of headphones said Chief Financial Officer Mitch Edwards
is resigning, effective April 1.  VeriFone Systems Inc. (PAY)   gained 7.9 percent to
$50.24, the highest price since May 10. The largest maker of
credit-card terminals forecast 2012 earnings may be as much as
$2.66 a share excluding some items, compared with the average
analyst projection of $2.60 a share.  Zeltiq Aesthetics Inc. (ZLTQ)  (ZLTQ US) tumbled 34 percent, the
most since it went public in October, to $7.36. The Pleasanton,
California-based maker of fat-reduction technology gave a
forecast of 2012 sales that trailed analysts’ estimates.  To contact the reporter on this story:
Inyoung Hwang in  New York  at 
 ihwang7@bloomberg.net   To contact the editor responsible for this story:
Nick Baker at 
 nbaker7@bloomberg.net  